Cano Health Inc. (NYSE:CANO) finished Thursday with a subtraction of -$0.01 to close at $1.52, a downside of -0.65 percent. An average of 8,356,120 shares of common stock have been traded in the last five days. There was a fall of -$0.0200 in the past week, and it reached a new high 9 times over the past 12 months. The last 20 days have seen an average of 4,132,575 shares traded, while the 50-day average volume stands at 4,542,528.
CANO stock has increased by 7.80% in the last month. The company shares reached their 1-month lowest point of $1.3000 on 07/27/23. With the stock rallying to its 52-week high on 02/08/23, shares of the company touched a low of $0.76 and a high of $9.75 in 52 weeks. It has reached a new high 7 times so far this year and achieved 10.95% or $0.1500 in price. In spite of this, the price is down -84.41% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
CANO stock investors should be aware that Cano Health Inc. (CANO) stock had its last reported insider trading activity 43 days ago on Jun 29. In this transaction, the insider spent $525,760. Chief Clinical Officer, Aguilar Richard, disposed of 150,000 shares at a price of $1.22 on Jun 28. The insider now owns more than $183,300 worth of shares. Prior to that, Chief Clinical Officer Aguilar Richard went on to Sale 500,000 shares at $1.42 each on Jun 12. An amount of $711,650 was transacted.
Valuation Metrics
Cano Health Inc. (CANO) stock’s beta is -0.01. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 0.26, the price-to-book (PB) ratio at 1.30.
Financial Health
Further, the company has a long term debt to equity ratio of 3.62 and a total debt to equity ratio of 3.65 for the quarter ending March 30. Cano Health Inc.’s EBITDA margin for the year ending March 30 is 0.60%, while its operating margin for the same period stands at -16.00%. Its gross profit as reported stood at $3.18 billion compared to revenue of $2.74 billion.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, Cano Health Inc.’s return on assets was -11.50%.
Earnings Surprise
For the three-month period that ended March 30, Cano Health Inc. had $1.01 billion in total debt. In the quarter under review, the net income was up than the previous quarter. The company posted a net income of -$28.15 million in the quarter, while revenues of -$148.37 million were grew 102.34%. The analyst consensus anticipated Cano Health Inc.’s latest quarter earnings to come in at -$0.12 per share, but it turned out to be -$0.12, a 0.00% surprise. For the quarter, EBITDA amounted to -$11.19 million. Shareholders own equity worth $536.07 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Cano Health Inc. (CANO) price momentum. RSI 9-day as of the close on 10 August was 51.15%, suggesting the stock is Neutral, with historical volatility in this time frame at 99.97%.
As of today, CANO’s price is $1.6300 -1.30% or -$0.0200 from its 5-day moving average. CANO is currently trading +8.57% higher than its 20-day SMA and +39.45% higher than its 100-day SMA. However, the stock’s current price level is +20.63% above the SMA50 and -64.57% below the SMA200.
The stochastic %K and %D were 65.91% and 78.79%, respectively, and the average true range (ATR) was 0.1316. With the 14-day stochastic at 50.00% and the average true range at 0.1261, the RSI (14) stands at 53.07%. The stock has reached 0.0278 on the 9-day MACD Oscillator while the 14-day reading was at 0.1029.
Analyst Ratings
UBS downgraded Cano Health Inc. (NYSE: CANO) to a a Neutral rating in its most recent analyst report. Previously, the stock was rated as a Buy. The consensus rating for Cano Health Inc. (CANO) among analysts is Hold. According to current brokerage recommendations, 1 brokerage firm advise that investors sell CANO, while 5 suggest investors hold. There are 1 analyst who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 3 others rate it as a “buy”.
What is CANO’s price target for the next 12 months?
Analysts predict a range of price targets between $1.00 and $5.50, with a median target of $2.75. Taking a look at these predictions, the average price target given by analysts for Cano Health Inc. (CANO) stock is $2.71.
